Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINTRAVENOUSGeneric

FLUDEOXYGLUCOSE F18

FLUDEOXYGLUCOSE F-18

Standard Dose
20-200mCi/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary

Approval overview FLUDEOXYGLUCOSE F18 is listed in Drugs@FDA under application 021870 (NDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient FLUDEOXYGLUCOSE F-18 Form and strength INJECTABLE;INTRAVENOUS - 20-200mCi/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor FEINSTEIN Submission history Latest submission status date: 2023-11-09 00:00:00.

Structured Monograph

Clinical summary

Approval overview FLUDEOXYGLUCOSE F18 is listed in Drugs@FDA under application 021870 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient FLUDEOXYGLUCOSE F-18 Form and strength INJECTABLE;INTRAVENOUS - 20-200mCi/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor FEINSTEIN Submission history Latest submission status date: 2023-11-09 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.
FLUDEOXYGLUCOSE F18 (FLUDEOXYGLUCOSE F-18) | Drug Monograph | MedicHelpline